Jupiter Neurosciences, Inc. (NASDAQ: JUNS)
Published June 11, 2026
Views 8.00K | Likes 507 | Comments 0
At a glance
Views
8,002
Likes
507
Comments
0
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
Jupiter Neurosciences, Inc. (NASDAQ: JUNS) is a clinical-stage pharmaceutical company focused on developing therapies for neuroinflammation and central nervous system disorders whose lead clinical program is advancing through a Phase IIa trial in Parkinson’s disease. Keynote speaker: Christer Rosén, Chairman & CEO, a…
- Published
- June 11, 2026
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.